Parkinson's disease — response to opicapone
1 article(s) in the watch · Pharmacogenomics
Effect of COMT and UGT1A Variants on Clinical Response to Opicapone in Parkinson's Disease.
Automatic aggregation page — a clinical introduction may be added.
A clinical genetics question? Tell us what you're looking for — the assistant is in the works.
Do not include any patient-identifying information.